Baxter International Inc. (NYSE:BAX) has appointed Jeffrey A. Craig, former executive chair and chief executive officer (CEO) of Meritor Corporation, to its board of directors. The addition of Mr. Craig, effective September 9, 2024, brings the total number of directors serving the company to 12.
Mr. Craig's appointment to Baxter’s Audit Committee is expected to complement the current board expertise with deep financial, broad operational, and public company board experience. His background as a former CEO, CFO, COO, and public company auditor is expected to provide valuable insights to the board.
Notably, Mr. Craig has held various leadership roles, including controller, chief financial officer, and president and chief operating officer at Meritor Corporation, a global supplier of drivetrain, mobility, braking, and aftermarket solutions for commercial vehicles. Before joining Meritor, he served as president of GMAC Commercial, a $10 billion finance provider to various industries. He also started his career at Deloitte, where he culminated in the role of audit partner and audit practice leader of its St. Louis office.
Baxter International Inc., a global medtech leader, offers a leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital, and surgical products used across patient homes, hospitals, physician offices, and other sites of care. The company's products, digital health solutions, and therapies are available in more than 100 countries.
The company's employees worldwide are working to build upon its rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations.
For more information about Baxter International Inc., visit www.baxter.com and follow the company on social media platforms. As a result of these announcements, the company's shares have moved 1.0% on the market, and are now trading at a price of $39.34. Check out the company's full 8-K submission here.
